MTEM Molecular Templates

Molecular Templates Inc is a clinical-stage biopharmaceutical company. It develops next generation immunotoxins known as Engineered Toxin Bodies for the treatment of individuals living with various cancer.

$0.85  +0.04 (4.43%)
As of 08/04/2022 16:00:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/04/2005
Outstanding shares:  56,339,205
Average volume:  137,415
Market cap:   $43,538,938
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYXC6T1

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%